Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring

NCT06464458 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

OTHER: management on hydroxyurea by therapeutic pharmacological monitoring

Sponsor

University Hospital, Strasbourg, France